Mesoderm development candidate 1 (MESDC1), also known as TLNRD1, is confirmed as an oncogenic function in bladder cancer and hepatocellular carcinoma (Tatarano et al., 2012; Wu et al., 2017). This evidence concerns the gene TLNRD1 and urinary bladder cancer.